Eitan Medical News
21 articles
Eitan Medical Receives ISO 14001 Environmental Management Certification
Eitan Medical has earned ISO 14001 certification for its quality management system in the production of medical devices, demonstrating its commitment to reducing negative environmental impact. The certification reflects the companys dedication to creating a more sustainable healthcare ecosystem. Eitan Medical develops connected drug delivery and infusion solutions that improve patient and clinician quality of life. The companys product lines include the Sapphire infusion platform, the Sorrel wearable drug delivery platform, and the Avoset infusion pump. Eitan Medical is focused on delivering reliable innovations that prioritize patient safety and care. The certification aligns with the companys values and commitment to global sustainability standards.
Customers
NHIA Welcomes Eitan Medical to its Future of Infusion Advisory Council
Eitan Medical has joined the National Home Infusion Associations Future of Infusion Advisory Council (FIAC) as part of a strategic partnership. The FIAC is a group of manufacturing and service companies focused on the home and alternate site infusion industry. Eitan Medicals addition to the council expands its international presence and will contribute to discussions on connected technology solutions for the industry. Eitan Medical develops drug delivery and infusion solutions for various healthcare settings. The partnership aims to improve the quality of infusion care for patients and enhance access to infusion solutions. The collaboration will help providers expand access to critical infusion services and monitor and improve patient care.
Partners
קיו קור של בועז איתן בדרך לנאסד"ק כלכליסט
Q Core, also known as Eitan Medical, is planning to merge with a SPAC (Special Purpose Acquisition Company) at a valuation of $1.3-1.4 billion. The company, which was acquired by Boaz Eitan 12 years ago, manufactures portable infusion systems. During the COVID-19 pandemic, Q Cores sales jumped to about $120 million per year. The company has also hired a foreign bank, likely Citibank, to facilitate the process. Q Cores main product is a portable infusion system that allows patients to receive infusions outside of the hospital. The companys products are sold in more than 25 countries.
AcquisitionPublic TradingExpand
Eitan Medical Announces Updated Distribution Arrangement
Eitan Medical has announced that it will become the exclusive supplier and service provider for its own Sapphire Infusion System, taking over from ICU Medical. Eitan Medical will also distribute administration sets manufactured by ICU Medical for the Sapphire Infusion System. The transition marks the completion of a successful partnership between the two companies. Eitan Medical aims to enhance patient care and safety through innovation and exceptional customer experience. ICU Medical will now focus on its Best in KLAS Plum platform and ICU Medical MedNet software. Eitan Medical is a leader in drug delivery solutions, with the Sapphire infusion system being its flagship device.
Partners
https://www.jpost.com/health-science/israeli-medtech-start-up-receives-european-medical-device-regulation-approval-661516
Eitan Medical, an Israeli medtech company, has received EU Medical Device Regulation (MDR) 2017/45 certification for the newest upgrades to its Sapphire™ infusion pump accessories and administration sets. This comes two months after the company received FDA approval for its system software Rev15. The products are used by clinicians in hospitals and home care environments across Europe for pain management therapies. The company prioritized securing MDR clearance early this year to meet the most stringent up to date standards and enhance quality for its customers.
Customers
Eitan Medical Receives FDA Clearance for Upgraded Sapphire™ Infusion Pump System
Eitan Medical has received FDA 510(k) clearance for its upgraded Sapphire infusion pump system software. The Sapphire infusion system is the companys flagship device used in various healthcare settings. The software upgrade includes key improvements such as adding the perineural route for pain management therapies, simplifying workflows, and enhancing maintenance functionality. Eitan Medical aims to provide innovative and reliable technologies that improve the user and patient experience. The clearance demonstrates the companys dedication to innovation and making their pumps easier to use for providers and safer for patients.
Customers
סורל מדיקל חתמה על הסכם שת"פ אסטרטגי עם חברת פארמה גדולה
Sorel Medical, part of the Eitan Group, has signed a strategic partnership agreement with a leading global pharmaceutical company. Sorel develops wearable infusion pumps for the continuous delivery of drugs into the body. Under the partnership, the companies will integrate their drugs into Sorels devices. The most advanced of these combined products may reach the market by the end of 2021, following clinical trials. Following the signing of the partnership agreement, which is expected to generate revenue even before market entry, the company will expand its clean room factory in Netanya and recruit additional employees.
PartnersExpand
ANDREI YOSEF, CEO, SORREL MEDICAL - ONdrugDelivery
Sorrel Medical, a subsidiary of Eitan Group, is a company focused on the development and manufacture of wearable drug delivery solutions. In an interview, CEO Andrei Yosef discusses Sorrels differentiated electro-mechanical, connected wearable injection platform. The company recently opened a state-of-the-art manufacturing facility and signed a significant partnership with a large pharmaceutical company. Sorrels wearable drug delivery platform is designed to provide a patient-centric and partner-focused solution for self-administration of medications. The devices utilize an electro-mechanical pumping mechanism and have integrated connectivity capabilities. Sorrel is currently in various stages of development for different device configurations and expects to have multiple clinical studies completed by the end of next year. The companys partnering strategy involves collaborating with multiple pharmaceutical partners to customize devices for specific drug delivery requirements. Sorrels business structure benefits from the expertise and infrastructure of Eitan Group.
PartnersExpand
https://www.jpost.com/health-science/sorrel-medical-partners-with-tier-one-pharmaceutical-company-635903
Sorrel Medical has entered a strategic partnership with a tier-one pharmaceutical company to develop its wearable drug injection delivery device. The partnership aims to address the challenges of wearable drug delivery and provide a solution that does not interfere with a pharmaceutical companys processes. Sorrels device is prefilled and preloaded with medication, allowing pharma companies to maintain the drugs quality and sterility while reducing costs and time-to-market. The device is also designed to be primary container agnostic, giving drug developers the freedom to use their own choice of primary container. It enhances patient adherence to therapy by providing a reliable and easy-to-use system. The device is attached to the patients body via a sticker patch and includes smart sensors and indicators for successful self-administration.
PartnersCustomers
Wearable Drug Delivery Provider Sorrel Medical Partners with Leading Global Pharmaceutical Manufacturer
Sorrel Medical has entered into a strategic partnership with a leading pharmaceutical company to develop and introduce next-generation wearable drug delivery solutions. The partnership will involve various molecule development initiatives across Sorrels wearable drug delivery platform. Sorrels on-body injectors are designed to enhance the patient experience and encourage adherence to treatment therapies. The devices are discreet, versatile, and attach to the patients body via a sticker patch. The partnership aims to provide safe, versatile, and easy-to-use devices for the changing nature of injectable drugs. Sorrel Medical is a medical device company focused on the development and manufacturing of wearable injectors for large volume and highly viscous therapies.
Partners
Sorrel Medical Opens New Manufacturing Facility, Increasing Clinical and Commercial Supply Capabilities of Wearable Drug Delivery Devices
Sorrel Medical has announced the opening of a new manufacturing facility with cleanroom facilities to accommodate the production of wearable drug delivery devices. The facility will support the companys growth and enable it to meet the needs of global pharmaceutical partner programs. The cleanroom is designed to reduce contamination and control environmental parameters. Sorrels wearable drug delivery devices are designed to enhance the patient experience and encourage adherence to treatment therapies. The company aims to bring next-generation drug delivery solutions to patients with chronic and high burden conditions.
PartnersExpand
Eitan Group Appoints Igal Shany as CEO of Eitan Group's Q Core Medical Ltd., and Eitan Group President
Eitan Group has announced the appointment of Igal Shany as the CEO of Q Core Medical Ltd. and President of Eitan Group. Shany is a veteran of the tech world and has experience in business development and marketing. He will be responsible for driving further expansion of the company across the care continuum with its innovative infusion products. The appointment is seen as a positive move for the companys growth. Eitan Group is focused on infusion therapy and technologies, developing systems for hospital care and wearable solutions for self-administration. The company aims to improve patient outcomes and establish itself as a leader in the infusion industry.
Management ChangesExpand
Sorrel Medical Appoints Bentsi Algazi Vice President of Operations, as Company Gears Up for Clinical and Commercial Manufacturing
Sorrel Medical has appointed Bentsi Algazi as Vice President of Operations to meet growing interest in its wearable self-injection devices. Algazi will oversee the companys supply chain, engineering, production, and vendor management activities. The appointment comes as Sorrels wearable drug delivery platform gains attention from leading pharmaceutical and biotech companies. Algazi brings over 20 years of managerial experience in R&D, operations, procurement, and production management. Sorrel is focused on the development and manufacturing of pre-filled wearable injectors for the self-administration of medications.
Management Changes
https://www.jpost.com/opinion/hillels-tech-corner-hospital-treatment-at-home-609341
Sorrel Medical, a company specializing in medical self-administration, aims to overcome the challenges of patient adherence and alternative drug delivery systems. They have developed a prefilled and preloaded device that allows pharmaceutical companies to maintain drug quality and sterility while reducing costs and time-to-market. The device is easily attached to the patients body and provides reliable and easy-to-use self-administration. Sorrels solution addresses the need for comfortable and independent medical treatment at home, reducing the need for hospital visits. The article expresses optimism about Sorrels mission and its potential to revolutionize healthcare.
CustomersExpand
Eitan Group launches preventative maintenance servicing tool for Sapphire infusion pumps - Drug Delivery Business
The Eitan Group has launched a new preventative maintenance servicing tool called FasTestPM for its Sapphire infusion pumps. The tool allows users to perform full maintenance tests on the pumps, reducing costs and runtime. It will cost 90% less than the previous maintenance kit and has a total runtime of four minutes. The company aims to revolutionize the concept of preventative maintenance by providing automatic, paperless tests that can be performed anywhere. The tool will officially launch in December at the ASHP Midyear Clinical Meeting and Exhibition in Las Vegas. The Eitan Group had previously signed a deal with InfuSystem for repair services on its Sapphire infusion pumps.
Customers
Avoset to develop infusion pump with unnamed pharma giant
Avoset Health plans to develop a connected infusion pump with an unnamed pharmaceutical company. The product is set to debut in early 2021. The technology allows physicians and pharmacists to track patient infusions and intervention needs.
Partners
Avoset Health to Develop Connected Dedicated Infusion Pump With Tier-one Global Pharma Partner
Avoset Health, a provider of connected infusion solutions for home care, has been selected by a leading manufacturer of medical devices and pharmaceutical products to develop a connected dedicated infusion pump. The pump is expected to be released in early 2021. Avosets technology allows its pumps to track patients treatment adherence through a cloud-connected system, providing data to healthcare providers for improved patient outcomes. Avoset is part of the Eitan Group, which is focused on developing connected infusion solutions across the care continuum.
Partners
Sorrel Medical's Wearable Drug Delivery Platform Wins 2019 MedTech Breakthrough Award
Sorrel Medical has been awarded the Best New Technology Solution in Drug Delivery designation from MedTech Breakthrough for its wearable drug delivery platform. The platform is designed to provide patients with a simple and efficient means of drug administration, particularly for large volume and high viscosity medications. Sorrels devices are discreet, fully-disposable, and able to meet a variety of specific drug requirements from multiple pharmaceutical partners. The devices utilize smart sensors and UV LED technology for successful self-administration and disinfection. They can also connect to Bluetooth and NFC platforms for sharing treatment information. The award recognizes Sorrels patient-centric approach to medical solutions.
Partners
From flash memory to drug delivery
Boaz Eitan, founder and CEO of technology company Saifun, left the company after a turbulent period that saw the company lose its main customer and its share price plummet. Saifun, which developed unique non-volatile memory technology, attempted to recover by merging with US company Spansion. However, Spansion was also hit hard in the financial crisis of 2008-2009 and went bankrupt. Eitan left the company and his shares were worth nothing. He then worked on building QCore Medical, a company developing infusion pumps.
Management ChangesAcquisitionLayoffs
Q-Core Medical to Open European Regional Headquarters in Marseille
Q-Core Medical Ltd. is opening a new European regional headquarters in Marseille, France. The company develops infusion pumps for hospital and ambulatory care. The pumps can be used for various IV therapies. Q-Core Medical was established in 2009 and employs 170 people.
Expand
Hospira Announces Significant Progess On Global Device Strategy
Hospira, Inc. has announced significant progress on its global device strategy, including the lifting of an import alert by the FDA on its infusion devices. This allows the company to sell these devices to new and existing customers without medical necessity certificates. Hospira also plans to launch new next-generation pump technology in 2015, as well as develop a next-generation platform of pumps in collaboration with partner Q Core Medical. The companys device strategy is aimed at addressing customer needs, supporting quality improvement efforts, and positioning the company for future growth. Hospira is a global leader in injectable drugs and infusion technologies.
Customers
